“I had come to realise that my research could contribute meaningfully to improvements in patient outcomes” – developing tests that could change clinical practice to personalise breast cancer treatment 04 Mar 2024 Personalised medicine is increasingly allowing us to provide individuals with the treatments most likely to be effective for them. In some cases, it might even spare people from unnecessary treatment. Isy Godfrey spoke with Dr Maggie Cheang, co-inventor of the Prosigna® Breast Cancer Prognostic Gene Signature Assay, to find out more. Find out more Show/Hide